Ultraviolet B (UVB) light is known to be immunosuppressive, but, probably because of a small UVC component in the emission spectra of some of the UVB lamps used, reports vary on effective dose levels. To prevent potentially lethal graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation, alloreactive donor T-cell activity must be suppressed. In this study, a narrow wavelength UVB lamp (TLO1.312 nm peak emission) was used to determine what doses of UVB were required to rlbolish rat lymphocyte proliferation while simultaneously preserving rat bone marrow progenitor cell and primitive hematopoietic stem cell viability. Lymphocyte proliferation, as measured by aH-Thymidine incorporation, in response to lectin stimulation was abolished below detection at doses greater than 3,500 J/mZ. When T-cell clonogenicity was measured in a limiting dilution assay, a small fraction (0.6%) was maintained at doses up t o 4,000 J/m2. Cytotoxic T-lymphocyte (CTL) activity was reduced after treatment with 4,000 Jim', but a significant HEN ALLOGENEIC bone marrow transplantation (BMT) is used as a treatment for leukemia, the lymphocytes in the graft can give rise to severe or lethal graftversus-host disease (GVHD). This can be prevented by T-cell depletion, but this is frequently associated with an increase in leukemia relapse and in graft reje~ti0n.l.~ The GVHD reaction is thought to have a graft-versus-leukemia (GVL) component:" Thus, by removing T cells, the GVL activity is also deleted. Graft rejection is brought about by residual host immunocompetent cells that have survived the conditioning regimen and can attack the graft that is no longer protected by counter-reactive T cells. Ultraviolet B (UVB) irradiation has been shown to abolish GVHD (alloreactivity) and host-versus-graft reaction (allostimulation) in a number of animal models."" Thus, in contrast to T-cell depletion, UVB-induced modification of allogeneic T cells allows them to aid engraftment without the risk of GVHD.
The major question to be addressed when irradiating a donor BM graft is to what extent are the BM hematopoietic stem cells damaged by doses of UVB that are capable of inhibiting the donor lymphocyte proliferation and thus the development of GVHD. It has been shown in various studies that lymphocytes are more sensitive to UVB than hematopoietic progenitor cells such as in vivo colony-forming unitspleen (Cm-S), in vitro colony-forming unit-granulocytemacrophage (Cm-GM), and erythroid burst-forming units (Bm-E).'8-Zo However, these progenitors are not necessarily indicative of damage to cells responsible for long-term engraftment. 21.22 Methods developed to assess damage to more primitive cell types include the marrow repopulating ability (MRA) assay,z3 discriminating cells capable of rescuing lethally irradiated animals, and, more recently, an in vitro limiting dilution assay that quantifies both hematopoietic progenitors and long-term repopulating hematopoietic stem cells on stromal cultures, the cobblestone area forming cell assay (CAFC)."-26 In the current study, a rat model was used in which the effects of various doses of UVB on rat lympho- level of cytotoxicity was s t i l l maintained. Natural killer cell cytolytic activity was not affected by doses up to 4,000 J/ ma. At 4,000 J/m2 there was a 10% survival of colony-forming units-granulocyte-macrophage; a 1% and 4% survival of day-8 and day-l2 colony-forming units-spleen, respectively; and 11% survival of marrow repopulating ability cells. Up to 25% of late cobblestone area forming cells (4 to 5 weeks), reflecting the more immature hematopoietic stem cells, were preserved in bone marrow treated with 4,000 J/m2, indicating that early stem cells are less sensitive to UVB damage than are more committed progenitor cells. Thus, a potential therapeutic window was established at approximately 4,000 J/mZ using this light source, whereby the potentially GVHD-inducing T cells were suppressed, but a sufficient proportion of the cells responsible for engraftment was maintained. 8 1996 by The American Society of Hematology.
cytes, derived from either the peripheral blood or spleen, and hematopoietic stem cells and progenitor cells were investigated. This was performed with a view to using this information in future studies for design of allogeneic transplant experiments in which it is hoped that UVB-irradiated grafts will be capable of protecting lethally irradiated animals, but GVHD will be inhibited. Because human BM contains approximately 20% to 30% T cells and there are much fewer in rat BM, splenocytes or peripheral blood lymphocytes (PBL) are frequently added to rat BM inocula for transplant to simulate human allogeneic BMT. Thus, when studying the effect of UVB on lymphocytes with a view to using this information to assess their GVHD-causing potential, it is also important to know how UVB affects BM cells.
One of the greatest problems when trying to compare work between different groups testing the sensitivity of different cell types to UVB light is the range of different lamps used. Most studies have been conducted using lamps that emit across a broad spectrum of the UVB emission range (280 to 320 nm) or in both the UVC (100 to 280 nm) and UVB range. UVB emitted at shorter wavelengths of the UVB region is more biologically effective than at longer wavelengths." Most measuring devices measure at all UVB wavelengths and do not distinguish the spectral region of emission. The most frequently used broad spectrum lamps are the TL12 (Philips, Eindhoven, The Netherlands),1J328 the FS20 (Westinghouse, San Gabriel, CA),6,9310,14320329 and the XX 15-B (Spectronics, Westbury, NY),11.18.19 emitting in the range of 250 to 375 nm (peak emittance, 312 nm).
In this study, the TLOl lamp (Philips) was chosen because it is a relatively monochromatic UVB source emitting over a narrow spectrum (3 12 to 313 nm) with hardly any emission in the lower UVB or W C regions. The dose required to abolish rat lymphocyte proliferation, as assessed by 'H-Thymidine incorporation and by lymphocyte clonogenic assays, was measured. The effect of W B on natural killer (NK) cell activity and cytotoxic T-cell activity was also measured. The extent to which similar doses of UVB damaged rat BM cells, over the entire range of maturation from committed progenitor cells (CFU-C and CFU-S) to the pluripotent stem cells (MRA and CAFC), was determined. Thus, a window was established whereby BM clonogenicity was retained and mature lymphocyte expansion was abolished.
MATERIALS AND METHODS

Animals
B6CBA (CBA X CS7B1/6; F, ) inbred male mice were bred in the animal facility at Erasmus University (Rotterdam, The Netherlands) and used between 8 and 12 weeks of age. WAGRij and Brown Norway (BN) inbred male rats were purchased from the Harlan breeding facility at Rijswijk, The Netherlands, and used at 10 to 14 weeks of age.
UVB Irradiation
Cells were irradiated in a biohazard laminar air flow cabinet using a bank of 8 TLOl Philips lamps with a peak emission at 312 nm. The delivered dose was monitored using a specifically calibrated Waldman meter (type 585100; Herbert Waldman GmbH & CO, Schwenningen, Germany). The meter was calibrated against two standards: (1) model 742 UV visible spectroradiometer (Optronic Laboratories Inc, Orlando, FL) and (2) model Kipp E-l 1 thermopile (Kipp, Delft, The Netherlands). Cells were irradiated at a rate of 10 J/mz/s on a shaking platform (60 rpm) in open petri dishes at a maximum cell density of 1 X 107/mL. The volume of 1 mL was 1 mm deep, and cells were maintained in serum-free RPMI medium on ice before, during, and after irradiation. The dose range was from 0 to 4,000 J/mz. Scanning spectrometry of the emission spectra of the TLOl and TL12, and the TLOl with and without the filtration effect of the plastic petri dishes, was performed at the Department of Photodermatology (University Hospital, Utrecht, The Netherlands). The spectrum of light responsible for DNA damage as established by SetlowZ7 was multiplied by the emission spectrum for the TLOl lamp to establish the most potentially damaging output wavelength from this lamp.
Lymphocyte Proliferation Assays
WAG/Rij PBL separated over lymphocyte separation medium (density, 1.077 g/mL; Nycomed Pharma AS, Oslo, Norway) or splenocytes made into a single suspension by pushing through a sterile nylon filter (not ficolled) were UVB irradiated. They were then plated in 96-well round-bottomed plates at a density of 2.5 X IO5/ well in 150 pL culture medium (RPMI 1640, supplemented with 10% [voVvol] heat-inactivated fetal calf serum [FCS], 100 IUlmL penicillin, 100 p g h L streptomycin, and 5 pg/mL ConA). Cell counts were not adjusted after UVB. After culture for 4 days at 37°C in a 5% humidified incubator, 0.5 pCi 3H-Thymidine/well was added and cells were incubated for a further 18 hours. Cells were then harvested onto skatron filters and counted by standard methods. 'HThymidine uptake was taken as a measure of the T-lymphocyte ability to proliferate after UVB irradiation.
Lymphocyte Clonogenicity Assay
Splenocytes, prepared as above, were UVB irradiated with various doses, plated in various dilutions in 96-well round-bottomed plates (1 plate per dilution) with a polyclonal expansion stimulus including ConA (5 pg/mL), interleukin-2 (IL-2; 25 IUlmL), 2-8 mercaptoethano1 mom), Indomethacine (5 X moVL), gamma-irradiated (25 Gy) BN spleen cells ( 104/well) and gamma-irradiated APD and BSM as feeder cells (5 X IO'/well; both Epstein-Barr virus [EBVI-transformed human B-cell lines).
Cytotoxicity Assay
Cytotoxic activity of T cells and NK cells was determined in standard 5'Chromium release assays. Briefly, various numbers of UVB irradiated effector cells, counted with eosin before irradiation, were seeded in triplicate in round-bottomed microtiter wells together with a fixed amount (n = 5,000) of target cells. Cell viability, as determined by counting with eosin, was not actually affected directly after UVB, and therefore the number of viable cells used in control and test groups was the same. NK activity was measured directly after UVB irradiation using fresh WAG/Rij spleen cells as effector cell population and YAC cells, an NK-sensitive murine Moloney leukemia virus-induced lymphoma cell line, as target cells. T-cellmediated cytotoxicity was determined directly after UVB irradiation in a reverse antibody-dependent cellular cytotoxicity test using WAG/Rij splenocytes cultured with polyclonal expansion stimulus (see lymphocyte clonogenicity assay) as effector cells and P815 cells, a Fc,R' mouse mastocytoma cell line, as target cells. Anti-T-cell receptor monoclonal antibody (MoAb) R73 was added to the effector cells 30 minutes before the addition of P815 target cells. The plates were incubated at 37°C for 4 hours. After incubation, the supernatants were collected and counted in a gamma counter. The percentage of specific cytotoxic activity was calculated using the following equation: (experimental release -spontaneous releasel maximum release -spontaneous release) X 100.
BM Progenitor and Stem Cell Assays
CFU-C assay. UVB-irradiated WAG/Rij BM cells were directly cultured on semisolid medium (methyl-cellulose 3%) in the presence of recombinant murine granulocyte-macrophage colony-stimulating factor (GM-CSF; 500 U/mL; Behring Werke AG, Marburg, Germany) and colonies were counted after 7 to 10 days.
CFU-S assay. Rat spleen colony-forming cells were assayed using the xenogenic rat-to-mouse assay as described in detail elsewhere." Briefly, B6CBA mice were lethally irradiated (8.7 Gy; dose rate, 1 Gylmin) using gamma irradiation from a Cesium source (Atomic Energy of Canada, Toronto, Ontario, Canada). They were then injected with fixed amounts of BN rat UVB-irradiated BM cells in a 0.5 mL volume (8 recipient mice/cell dose). Mice were housed in a laminar air flow cabinet and killed after 8 or 12 days. Spleens were fixed and the colonies on the surface were counted. The number of colonies was corrected to the number per IO6 cells injected.
MRA.
Lethally irradiated (10 Gy; dose rate, 1 Gy/min, gamma irradiation) BN recipient rats were injected with lo7 UVB-irradiated WAGlRij BM cells. After 1 I days, the recipients were killed and BM from single femurs was harvested individually. Fractions of BM cells from femurs ranging from 1/75 to 1/1,200 femur were then plated on methyl-cellulose in triplicate with murine GM-CSF as in the CFU-C assay and colonies were counted after 7 to 10 days. Results were then converted to the number of CFU-C per femur.
CAFC. Mouse (B6CBA) femora and tibias were cleaned of muscle tissue and ground to make a BM cell suspension. The cells were then cultured in gelatin-coated 96-well plates (2 femora and tibias/ 2.5 plates, 200 pUwell) until there was a confluent stromal monolayer (2 to 3 weeks). During this time, a medium, containing 10% FCS and 5% horse serum, was used and half of the medium was changed weekly. The stroma plates were then gamma irradiated (20 Gy) and, 4 to 7 days later, they were overlaid with UVB irradiated WAGlRij BM cells in various dilutions ranging from 100,OOO to 50 cells per well (15 wells/dilution) or nonirradiated control BM. The overlaid cells were maintained in 20% horse serum containing 2% rat IL-3 (supernatant from monkey COS-l cells transfected with the rat IL-3 gene; details described elsewhere"). Five, 7, and 9 days thereafter, they were scored as being positive or negative at each dilution for cobblestone areas (phase dark areas by phase contrast microscopy). Thereafter, they were scored once weekly. When 37% of the wells were negative for a particular dilution, it was calculated that, on average, there was one CAFC per number of cells plated (Poisson statistics). Details of the procedure are described elsewhere.24 The percentages of surviving cobblestone areas relative to the nonirradiated control were compared with the percentages of surviving colony-forming units in the more frequently used BM progenitor cell assays (CFU-C and CFU-S) and the MRA assay.
RESULTS
UVB Output of the TLOI Lump
The emission spectrum of the TLOl lamp was compared with the TL12 lamp that has a similar output to other broad spectrum lamps (Fig 1A) . This shows that the output of the TLOl lamp is almost entirely in the UVB region, whereas in the TL12 lamp there is also a small output in the UVC region (0.134%) and considerable emission in the shorter UVB wavelengths. In our initial experiments to optimize conditions of UVB irradiation, we performed CFU-GM and lymphocyte proliferation assays with lids on the petri dishes during irradiation and irradiated for a longer time to compensate for the 20% lower amount of UVB transmitted through the plastics. However, when this was performed, it was observed that CFU-GM were damaged at lower doses than lymphocyte proliferation was inhibited (data not shown). When irradiating with lids off the petri dishes, lymphocyte proliferation was abolished at doses at which CFU-GM and other bone marrow progenitors survive (see below). Using the plastic petri dish lids as a filter, the emission spectra of the T L O l lamp were compared with and without a filter. It was found that the filters selectively filtered out some of the low amount of radiation emitted in the high UVC region and low UVB region only visible when plotted on a log scale (Fig 1B) . When these emission spectra were combined with the spectrum established by SetIow2' as being responsible for DNA damage (Fig lC) , it was calculated that, without filters, 4 4 % of the DNA damage occurs in the 250 to 300 nm region, but, with filters, only 20% occurs in this region. Thus, there was a significant difference in DNA-damaging potential of even very small differences in emission spectra. This experiment also showed that, although the TLOl lamp was chosen because it was the best available lamp with monochromatic emission in the high W B (3 12 nm) region and hardly any contaminating UVC (0.001%), the very low amount of emission in the lower UVB region (280 to 300 nm) might be responsible for abolishing lymphocyte proliferation while maintaining BM cell clonogenicity.
T-Lymphocyte Proliferation After UVB Irradiation
Lymphocyte proliferation assays measured 3H-Thymidine incorporation to assess proliferation of T cells in vitro after UVB irradiation. The proliferative response of WAGRij PBL to ConA was reduced to less than 10% at doses exceeding 2,000 J/m2 (Fig 2) . The proliferative response of WAG/Rij splenocytes that were ficolled was inhibited to the same extent at similar doses. ConA-induced proliferation of splenocytes that were not separated over ficoll was initially stimulated by lower doses of W B (up to 2,500 J/m2), but activity was abolished to 30% by 3,000 J/m2 and to below a detectable level at 4,000 J/m2. The ConA-induced stimulation of splenocyte proliferation above control values at low doses of UVB irradiation was consistently seen. This phenomenon was also observed in PBL and ficolled splenocytes irradiated at very low doses (50 to 200 J/m2) in initial setup experiments (data not shown). Comparable lymphocyte responses were seen using BN-derived cells in parallel assays.
To determine whether the dose-dependent inhibition of T-cell proliferation was due to cell death, we determined lymphocyte viability at 0, 24, and 72 hours postirradiation. Lymphocyte viability, as assessed by propidium iodide exclusion, shows that UVB-irradiated lymphocytes are killed in a dose-related manner, and although this loss of viability cannot be detected directly after irradiation, it is clearly visible after 24 hours in both splenocytes and PBL (data not shown). However, approximately 10% to 20% of the cells remained viable 24 hours after high doses of UVB, although their proliferation was abolished. Because a fraction of the cells remained viable even after high doses of UVB irradiation, as determined by propidium dye uptake, but there was no proliferation detected using the 3H-Thymidine uptake assay, there was the possibility that the remaining viable cells may have been capable of proliferating, but, with 90% of the cells being dead, this may suppress the potential proliferative capacity of the live cells. Therefore, a limiting dilution assay of the irradiated splenocytes was performed. Cells were counted using eosin before irradiation with UVB. After UVB irradiation, they were cultured with a polyclonal stimulus and feeder cells to provide all the necessary growth factors for viable cells to expand if they were capable of doing so. Wells were scored 7 and 14 days after plating. Results were analyzed by Poisson statistics, for which 37% negative wells indicate an average of 1 clonogenic cell/well. From this it appeared that, even though there are more than 20% of cells remaining viable 24 hours after irradiation with 4,000 J/m2 UVB, these cells are not capable of expansion, because only 0.6% of the irradiated lymphocytes expanded with the polyclonal expansion stimulus ( Table 1) .
Effect of UVB on Cytotoxicig
The purpose of this assay was to determine whether cytotoxic T-lymphocyte (CTL) and NK cell activity was abolished directly after UVB irradiation. Results showed that UVB diminished CTL activity in a dose-responsive manner (Fig 3A) . However, at a dose of 4,000 J/m2, a significant amount of cytolytic activity was still maintained. From the results in Fig 3B, it is clear that NK cell cytotoxicity exerted by fresh splenocytes is not hampered by UVB, as YAC cells were lysed to the same extent by irradiated (up to 4,000 J/ m' ) and control WAGRij splenocytes.
Survival of BM Progenitor Cells After UVB Irradiation CFU-C. One of the most conventional methods to assess damage to BM cells is to test for loss of colony-forming ability of c o d t t e d progenitor cells in in vitro assays. WAG/Rij CFU-GM production was reduced in a dose-responsive manner, but 10% of CFU-GM formation was retained at a dose of 4,000 J/m2 (Fig 4) . Similar results were seen using BN rat BM (data not shown). J/m2 (Fig 5) . However, the spleen colonies measured on day 12, which represent colony formation by less mature progenitors than those found on day 8, showed approximately 4% survival after 4,000 J/m2, indicating that the more immature progenitors are slightly less sensitive to the damaging effects of W. BN marrow was used in this instance as the spleen colony assay using WAG/Rij B M results in colonies that are very small making it difficult to count accurately. MRA in an allogeneic setting. Our results indicate that at least 50% of MRA was retained at doses of 2,500 to 3,000 J/m2 (Fig 6) and only at 4,000 J/mz was it reduced to 11% of the control value. This indicates that at least 11% of the very immature B M progenitor cells, capable of radioprotection, were preserved at a dose of 4,000 J/m2.
CFU-S. After injection of graded numbers of BN BM cells irradiated with various doses of UVB into lethally irradiated mice (n
Effect of W B on
Effect of UVB on CAFC
There was a high frequency of cobblestone areas (ie, areas of blast cells underneath the stromal layer that can be clearly Resub are expreswd as the means of three experiments f standard error of the mean.
DISCUSSION
The emission spectra of the TLOl lamp compared with that of the TL12 lamp shows the difference in output of the lamp used in this study compared with those used in other studies. The TL12 lamp has a similar output spectrum to other broad spectrum lamps that are used in most investigations examining the effects of UVB. The broad spectrum lamps have a small, but measurable, output in the UVC region and considerable output in the shorter wavelengths of the UVB region. As was observed from filtering the TLOl output with plastics, even the smallest difference in the highly harmful UVC region and lower UVB region of the spectrum can cause a significant difference in damage to cells. This selective shorter wavelength filtration by plastics could play an important role when cells are irradiated in plastic bags, which sometimes happens with platelet concentrates." This emphasizes that each factor that may interfere with the delivery of light to the cells must be controlled carefully.
Using the conditions described, UVB is clearly able to inhibit T-lymphocyte proliferation below the detection limits of our assay, whereas clonogenicity of BM cells is maintained to a certain extent. However, the viability of lymphocytes, as determined by propidium iodide dye exclusion, was maintained at similar levels to CFU-GM clonogenicity in that there are approximately 10% lymphocytes remaining alive up to 24 hours after treatment with 4,000 J/m2. It is possible that some of these remaining cells may still have been capable of proliferating but were inhibited from doing so by the relatively large amount of dead or dying cells in the culture. Alternatively, the reduction of stimulatory factors such as IL-2, brought about by UVB,28 may have been responsible for the inhibition of proliferation. To test whether this was indeed so, the limiting dilution assay, a T-cell clonogenic assay, was performed. In this assay multiple stimuli (ConA, allogeneic gamma-irradiated feeder cells, and IL-2) were used. These conditions in principle allow the expansion of almost every T cell irrespective of its specificity. Only 0.6% of clonogenic lymphocytes treated with 4,000 J/m2 were truly able to proliferate in response to this polyclonal stimulus. Interference with antigen presentation after UVB may also be responsible for the reduction in response. Dendritic cells, important accessory cells in mitogen driven cultures, have been shown to be very sensitive to UVB'3 in that the dendritic cell signal necessary for T-cell interaction is diminished.
In the current experiments, unficolled splenocytes were less sensitive to UVB than ficolled splenocytes or PBL and thus required higher doses to inhibit their proliferation. This is probably due to the fact that there are a large number of red blood cells in the unficolled cell suspensions that may shield the spleen T cells during irradiation. Hence, these cells were actually exposed to lower doses than their ficolled counterparts and responded initially by being stimulated above control values up to 2,000 J/m2 as did ficolled cells in earlier experiments when exposed to doses less than 200 J/m2. This indicates that low doses of UVB enhanced rather than inhibited ConA-induced proliferation of lymphocytes. recognized using phase contrast microscopy) at early time points after overlay on stroma (Fig 7A) . The frequency of CA in the control on day 7 was approximately 35 per 100,OOO cells plated. CA that appear on days 5, 7, and 9 represent committed progenitors, just as colonies found in the CFU-C and CFU-S day 8 assays do. At 28 days after overlay of BM, when the more immature cells give rise to CA, the frequency of CAFC was as expected much lower at 4/ 100,000 cells plated. The reduction of CA formed by UVB irradiated BM cells at early time points shows that the clonogenic potential of the more differentiated stem cells was decreased. Only 20% CAFCs, by comparison with the control, are found on day 7 after 3,000 J/m2 (Fig 7B) , and that is further reduced to less than 10% when overlaid BM was treated with 4,000 J/m2. The frequency of CA found on day 28 after overlay was not affected by 2,500 J/m2; approximately 30% still survived after 3,000 J/m2 and 15% after 4,000 J/m2. On day 35 after overlay, the percentage of CAFC appearing relative to the control increased, with 25% survival after 4,000 J/m2 (Fig 7C) . Thus, the frequency of earlier appearing CAFC is reduced to a greater extent in response to UVB than those appearing later. CAFC appearing after 28 days in culture are thought to represent the most immature hematopoietic stem cells, including the long-term repopulating ability cells, and thus these results indicate that pluripotent stem cells are less sensitive to the damaging effects of UVB than are committed progenitors. These data are plotted in Fig 7A to indicate that, in untreated BM, the frequency of CAFC is much lower at later times after overlay than within the first 14 days. In Fig 7B, the same data are plotted as a direct comparison of the extent to which treated BM is affected. In Fig 7C, The red blood cells were not removed when BM cells were being irradiated, and thus the comparison of unficolled splenocyte activity with BM cell survival is most relevant.
The delayed death of lymphocytes after UVB was not cytokine production (IL-2, IFN-7, and TNF-a) was reduced in a dose-responsive manner, whereas IL-2 receptor expression was not affected. CTL activity was partly inhibited and NK activity was not inhibited by UVB irradiation up to 4,000 J/m2. Loughran et found that NK activity of canine cells was completely eliminated with doses as low as 16 J/ m2. However, the lamp used in that study emitted in the UVC-UVB region (200 to 300 nm). In this study, the NK and CTL activities were measured directly after cells were irradiated with UVB, at which time they were all still viable, as measured by propidium iodide uptake. From the thymidine uptake experiments, it can be seen that T-cell ability However, although the CTL cells were not capable of subse-
Days after overlay
quently proliferating, some of their established cytolytic activity was maintained. However, it is highly improbable that there would be any further generation of CTL activity after UVB. Uharek et al" have shown that NK activity can induce a GVL reaction independent of the GVH reaction. It is well documented that UVB can inhibit GVHD by inhibition of T-cell proliferation. However, if NK and CTL activity is maintained, as observed here, in vivo, and this activity can effect a GVL reaction, UVB treatment of allogeneic transplants may be able to provide the benefit of GVL activity without the risk of lethal GVHD.
Results of CFU-C and CAFC measurements for day 7 correlated very closely. Both assays showed that 2,500 J/m2
reduced colony formation to 30% of control, 3,000 J/m2 gave approximately 20% survival, and at 4,000 J/m2 less than + 3oOoJ/m2 10% survived. Referring to correlation studies performed (manuscript in preparation) in the rat, it appears that the survival of later appearing cobblestones compared with those that appear earlier after overlay represent the most primitive stem cells and that these are more resistant to UVB than later progenitor cells. This may be because the early cells are resting, and resting cells have been shown to be less susceptible to (drug-induced) damage. 23 Other studies that have investigated the influence of UVB on BM in vitro have concentrated on CFU-C and CFU-SI9 (in vivo) and these cells, although important in short-term radioprotection, are not capable of producing long-term chimeras.2' Here, the effect of UVB on the more immature hematopoietic stem cells was also investigated to see how early stem cells were influenced compared with the more mature progenitors. It was found that U V B damaged the more primitive cells to a lesser extent than the committed progenitors.
All of the lymphocyte and BM cell proliferation assays in this study, except for the CFU-S assay, were performed using cells of WAG/Rij origin. The CFU-S assay was performed using BM cells of BN rat origin. Rauchwerger et a136 reported that, when using the xenogenic CFU-S assay, only certain rat into mouse combinations give good results. The BN rat into the B6CBA is one such established combination. As we performed parallel CFU-GM and lymphocyte proliferation assays using BN cells and found the results to b e similar to using cells of WAGRij origin, we concluded that it was reasonable to use cells of BN origin in this assay to estimate the effect of UVB on the CFU-S population.
From these experiments it can be concluded that it is possible to maintain NK and CTL cytotoxicity and a sufficient fraction of the BM clonogenicity at doses of UVB that exert a 2 log reduction of lymphocyte proliferation. This establishes a potential window of opportunity whereby this information can be used to design in vivo experiments. The aim of such experiments would be to establish whether GVHD can b e abolished in allogeneic BMT using this source of UVB and whether the GVL activity observed in an experimental rat leukemia model4 (Brown Norway myelocytic leukemia) relevant to human acute myelocytic leukemia is simultaneously lost or maintained. This is currently under investigation.
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